Lactobacillus helveticus and blood pressure
What 2 graded rows on lactobacillus helveticus agree on for blood pressure, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Lactobacillus helveticus page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Lactobacillus helveticus page, with its PubMed record.
Your question
Lactobacillus helveticus and blood pressure
2 rows · 183 peopleSplit. 1 row found an improvement and 1 found no difference.
- CGrade C× 1
- ∅No effect× 1
- Rows
- 2
- Trials
- 2
- People
- 183
Where they differ
From the rowsThe best-graded row, grade C, is a randomized trial of 94 people (2005) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.
The row that found no difference ran longer (3 months) than the row that found an improvement (2 months).
The row that found no difference is newer (2012) than the row that found an improvement (2005).
The rows
1 improved · 1 no difference- CGrade C24-hour blood pressure in hypertension · Improved
RCT · n 94 · 2005 · Untreated adults with hypertension in Finland
150 mL twice a day · 10 weeks
Systolic pressure fell 4.1 mm Hg (P = .001) and diastolic 1.8 mm Hg (P = .048) more than control; adverse events did not differ.
Row on the Lactobacillus helveticus page · PubMed 16364832 (opens PubMed)
- ∅No effect24-hour blood pressure with lactotripeptide milk · No difference
RCT · n 89 · 2012 · Adults with mild hypertension in Finland
5 mg then 50 mg lactotripeptides a day · 3 months per dose
5 mg a day did not lower blood pressure; 50 mg lowered it from baseline, but the differences vs placebo (-2.6/-1.3 mm Hg) were not significant.
Row on the Lactobacillus helveticus page · PubMed 22617279 (opens PubMed)